Abstract
Reports on sudden cardiac death (SCD) of children and adolescents treated with stimulant agents have raised concerns regarding
the need for cardiovascular monitoring and risk stratification schedules. Cardiac ventricular late potentials (LPs) represent
delayed ventricular activation that might predispose to fatal ventricular arrhythmias and SCD in cardiac patients. LPs have
not previously been measured in children with attention deficit/hyperactivity disorder (ADHD). LPs were measured in 18 physically
healthy ADHD children (5 girls and 13 boys, age 11.9 ± 2.5 years, treatment duration 2.6 ± 1.9 years) before and 2 h after
oral methylphenidate administration. No significant changes were detected and LPs were found to be within normal ranges. In
conclusion, this preliminary small-scale study suggests that methylphenidate in physically healthy children with ADHD was
not associated with cardiac ventricular LPs, suggesting the safety of the agent in this age group.
the need for cardiovascular monitoring and risk stratification schedules. Cardiac ventricular late potentials (LPs) represent
delayed ventricular activation that might predispose to fatal ventricular arrhythmias and SCD in cardiac patients. LPs have
not previously been measured in children with attention deficit/hyperactivity disorder (ADHD). LPs were measured in 18 physically
healthy ADHD children (5 girls and 13 boys, age 11.9 ± 2.5 years, treatment duration 2.6 ± 1.9 years) before and 2 h after
oral methylphenidate administration. No significant changes were detected and LPs were found to be within normal ranges. In
conclusion, this preliminary small-scale study suggests that methylphenidate in physically healthy children with ADHD was
not associated with cardiac ventricular LPs, suggesting the safety of the agent in this age group.
- Content Type Journal Article
- Category Original Contribution
- Pages 1-4
- DOI 10.1007/s00787-011-0233-x
- Authors
- Eitan Nahshoni, The Davidoff Cancer Center, Rabin Medical Center, 39 Jabotinski St., 49100 Petach Tikva, Israel
- Pavel Golubchik, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Jonathan Glazer, Child and Adolescent Psychiatry Division, Child and Adolescent Clinic, Geha Mental Health Center, Petach Tikva, Israel
- Jonathan Sever, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Boris Strasberg, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Shula Imbar, Heart Institute, Rabin Medical Center, Petach Tikva, Israel
- Gal Shoval, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Abraham Weizman, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Gil Zalsman, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Journal European Child & Adolescent Psychiatry
- Online ISSN 1435-165X
- Print ISSN 1018-8827